Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
23 hedge funds and large institutions have $5.01M invested in Calithera Biosciences, Inc in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
5% more funds holding
Funds holding: 22 → 23 (+1)
0% less capital invested
Capital invested by funds: $5.02M → $5.01M (-$18.2K)
78% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
+$107K |
| 2 |
JP Morgan Chase
New York
|
+$10.2K |
| 3 |
ACP
Arcus Capital Partners
Atlanta,
Georgia
|
+$597 |
| 4 |
Morgan Stanley
New York
|
+$41 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$225K |
| 2 |
Renaissance Technologies
New York
|
-$114K |
| 3 |
Primecap Management
Pasadena,
California
|
-$32K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.55K |
CALA Hedge Fund Activity: Q4 2022 in Review
23 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2022, worth a combined $5.01M — down 0.36% from $5.02M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CALA positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 9 trimmed.
The largest buyer was TSP Capital Management Group, opening a new position worth an estimated $107K. The largest seller was Vanguard Group, cutting an estimated $225K.
- 23 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2022, up from 22 in Q3 2022.
- Funds reported $5.01M of Calithera Biosciences, Inc stock for Q4 2022, down 0.36% quarter-over-quarter.
- 4 funds opened new Calithera Biosciences, Inc positions in Q4 2022 and 3 closed out, a net change of +1 holder.
- The largest Calithera Biosciences, Inc buyer in Q4 2022 was TSP Capital Management Group, an estimated $107K added.
- The largest Calithera Biosciences, Inc seller in Q4 2022 was Vanguard Group, an estimated $225K sold.
Based on aggregated 13F filings for Q4 2022.